Tara E. Soumerai

6.9k total citations
11 papers, 73 citations indexed

About

Tara E. Soumerai is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Tara E. Soumerai has authored 11 papers receiving a total of 73 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Epidemiology and 2 papers in Neurology. Recurrent topics in Tara E. Soumerai's work include COVID-19 and healthcare impacts (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Neuroblastoma Research and Treatments (2 papers). Tara E. Soumerai is often cited by papers focused on COVID-19 and healthcare impacts (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Neuroblastoma Research and Treatments (2 papers). Tara E. Soumerai collaborates with scholars based in United States. Tara E. Soumerai's co-authors include David M. Hyman, Debyani Chakravarty, Bruce A. Chabner, Mihir Kamdar, Michael F. Berger, Sarah Phillips, David B. Solit, Justin F. Gainor, Genevieve M. Boland and Alison M. Schram and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Tara E. Soumerai

10 papers receiving 73 citations

Peers

Tara E. Soumerai

ONCOL

MB

CR

EPIDE

PRM

Nabeel Badri United States

Hana Zahed France

Leslie E. Oldfield Canada

Richard Papworth United Kingdom

Susan Hasanpour‐Heidari Iran

Anne Sophie Carret Canada

Ted Trimble United States

Habib El‐Khoury United States

Sharat Chopra United Kingdom

Angela Stefania Ribecco Italy

Nabeel Badri United States

Tara E. Soumerai

50 ×1.5

ONCOL

20 ×0.7

MB

25 ×1.6

CR

8 ×0.9

EPIDE

5 ×0.6

PRM

Citations per year, relative to Tara E. Soumerai Tara E. Soumerai (= 1×) peers Nabeel Badri

Countries citing papers authored by Tara E. Soumerai

Since Specialization

Citations

This map shows the geographic impact of Tara E. Soumerai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara E. Soumerai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara E. Soumerai more than expected).

Fields of papers citing papers by Tara E. Soumerai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara E. Soumerai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara E. Soumerai. The network helps show where Tara E. Soumerai may publish in the future.

Co-authorship network of co-authors of Tara E. Soumerai

This figure shows the co-authorship network connecting the top 25 collaborators of Tara E. Soumerai. A scholar is included among the top collaborators of Tara E. Soumerai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara E. Soumerai. Tara E. Soumerai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Soumerai, Tara E., Therese M. Mulvey, Vicki A. Jackson, & Inga T. Lennes. (2024). Supportive Care for Cancer Patients Via Telehealth. The Cancer Journal. 30(1). 27–30. 1 indexed citations

2.

Soumerai, Tara E., et al.. (2023). Case 20-2023: A 52-Year-Old Man with a Solitary Fibrous Tumor and Hypoglycemia. New England Journal of Medicine. 388(26). 2467–2477. 5 indexed citations

3.

Bhattarai, Tripti Shrestha, Tambudzai Shamu, Alexander N. Gorelick, et al.. (2022). AKT mutant allele-specific activation dictates pharmacologic sensitivities. Nature Communications. 13(1). 2111–2111. 26 indexed citations

4.

Soumerai, Tara E., et al.. (2021). Inpatient chemotherapy for patients with advanced solid tumors: A single-center observational study.. Journal of Clinical Oncology. 39(28_suppl). 158–158. 1 indexed citations

5.

Zubiri, Leyre, Rachel Rosovsky, Meghan J. Mooradian, et al.. (2021). Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center. The Oncologist. 26(8). e1427–e1433. 11 indexed citations

6.

Reynolds, Kerry L., Samuel J. Klempner, Aparna R. Parikh, et al.. (2020). The Art of Oncology: COVID-19 Era. The Oncologist. 25(11). 997–1000. 7 indexed citations

7.

Soumerai, Tara E., Mihir Kamdar, & Bruce A. Chabner. (2019). The Other Opioid Crisis: Just Another Drug Shortage?. The Oncologist. 24(5). 574–575. 5 indexed citations

8.

Aghajanian, Carol, Deborah F. DeLair, Rachel N. Grisham, et al.. (2017). Somatic mutations in homologous recombination pathway genes in ovarian cancer.. Journal of Clinical Oncology. 35(15_suppl). 5545–5545. 4 indexed citations

9.

Raj, Nitya, et al.. (2016). Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT.. Journal of Clinical Oncology. 34(4_suppl). 246–246. 8 indexed citations

10.

Raj, Nitya, et al.. (2016). Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT.. Journal of Clinical Oncology. 34(15_suppl). e15661–e15661.

11.

Chakravarty, Debyani, Sarah Phillips, Jianjiong Gao, et al.. (2016). OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer.. Journal of Clinical Oncology. 34(15_suppl). 11583–11583. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact